Health Care & Life Sciences » Biotechnology | ARCA biopharma Inc.

ARCA biopharma Inc.

ARCA biopharma Inc.
Stock Exchange NASDAQ Stock Market
EPS
$8.54
Market Cap
$7.63 M
Shares Outstanding
1.41 M
Public Float
13.75 M

Profile

Address
11080 CirclePoint Road
Westminster Colorado 80020
United States
Employees -
Website http://www.arcabiopharma.com
Updated 07/08/2019
ARCA biopharma, Inc. is a biopharmaceutical company, which develops genetically targeted therapies for heart failure and other cardiovascular diseases. The company engages in cardiovascular pathophysiology, molecular genetics and clinical development. Its product candidate, GencaroTM is a pharmacologic beta-blocker and mild vasodilator, which is developed for the treatment of chronic heart failure and other indications.

Financials

View All

Michael R. Bristow
President, Chief Executive Officer & Director
Anders D. Hove
Director